Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
tremelimumab
Pharma
BMS claims AstraZeneca's Imjudo violates two Yervoy patents
Bristol Myers Squibb has opened a new front in its immuno-oncology patent fight with AstraZeneca, this time targeting Imjudo.
Fraiser Kansteiner
Jan 24, 2023 4:13pm
AZ's Imjudo faces more fierce competition after new cancer nod
Nov 11, 2022 10:00am
'The Top Line': Biogen's earnings call, AstraZeneca's CTLA-4 nod
Oct 28, 2022 6:00am
AstraZeneca's CTLA-4 drug treme finally snags its first approval
Oct 24, 2022 10:48am
FDA accepts AZ's application for tremelimumab in liver cancer
Apr 25, 2022 9:29am
AZ's R&D chiefs talk roxadustat, Imfinzi-treme
Feb 10, 2022 10:13am
